Protocol for cluster investigations to measure influenza vaccine effectiveness in the EU/EEA
Interim technical guidance on public health use of influenza antivirals during influenza pandemics
Antiviral drugs are an important addition to the public health arsenal against influenza. This interim guidance discusses the options for their effective use, especially during a pandemic.
Interim technical guidance on use of specific pandemic influenza vaccines during the H1N1 2009 pandemic
This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.
Influenza communication guide: How to increase influenza vaccination uptake and promote preventive measures to limit its spread
The influenza vaccination communication guide provide advice, guidance and campaign materials to support national influenza vaccination campaigns with the purpose of increasing the influenza vaccination uptake in the EU Member States.
NHS Employers (UK): Flu Fighter Campaign
Throughout the flu season, the National Health Service (NHS) in the United Kingdom provides advice, guidance and campaign materials to support local staff flu vaccination campaigns. Each season, the NHS provides employers with tools and resources that will help them run an effective flu fighter campaign and support resilience plans for winter pressures. NHS Employers works in partnership with Public Health England, supported by the Department of Health, to deliver the national seasonal flu campaign for NHS staff.
Types of seasonal influenza vaccine
Injected trivalent inactivated influenza vaccines are most commonly used throughout the world. Influenza antigen preparation varies between manufacturers. The inactivated influenza vaccines available in the EU/EEA may contain either split virion influenza virus products or subunit influenza products.